658 related articles for article (PubMed ID: 16357141)
21. Acute renal failure during sepsis: potential role of cell cycle regulation.
Yang QH; Liu DW; Long Y; Liu HZ; Chai WZ; Wang XT
J Infect; 2009 Jun; 58(6):459-64. PubMed ID: 19428114
[TBL] [Abstract][Full Text] [Related]
22. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
23. Cyclin D1-dependent kinase activity in murine development and mammary tumorigenesis.
Landis MW; Pawlyk BS; Li T; Sicinski P; Hinds PW
Cancer Cell; 2006 Jan; 9(1):13-22. PubMed ID: 16413468
[TBL] [Abstract][Full Text] [Related]
24. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
Auld CA; Fernandes KM; Morrison RF
J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
[TBL] [Abstract][Full Text] [Related]
25. Silibinin efficacy against human hepatocellular carcinoma.
Varghese L; Agarwal C; Tyagi A; Singh RP; Agarwal R
Clin Cancer Res; 2005 Dec; 11(23):8441-8. PubMed ID: 16322307
[TBL] [Abstract][Full Text] [Related]
26. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho AD; Goldschmidt H; Hehlmann R
Leukemia; 2002 Sep; 16(9):1844-51. PubMed ID: 12200702
[TBL] [Abstract][Full Text] [Related]
27. Involvement of cyclin D1/CDK4 and pRb mediated by PI3K/AKT pathway activation in Pb2+ -induced neuronal death in cultured hippocampal neurons.
Li C; Xing T; Tang M; Yong W; Yan D; Deng H; Wang H; Wang M; Chen J; Ruan D
Toxicol Appl Pharmacol; 2008 Jun; 229(3):351-61. PubMed ID: 18353414
[TBL] [Abstract][Full Text] [Related]
28. [Flow cytometric detection and significance of four cyclins in esophageal cancer].
Du Y; Wang XL; Wu GX; Wang YJ; Yang HC; Zuo LF
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):612-4. PubMed ID: 15634523
[TBL] [Abstract][Full Text] [Related]
29. The inhibition of T-cells proliferation by mouse mesenchymal stem cells through the induction of p16INK4A-cyclin D1/cdk4 and p21waf1, p27kip1-cyclin E/cdk2 pathways.
Kim JA; Hong S; Lee B; Hong JW; Kwak JY; Cho S; Kim CC
Cell Immunol; 2007 Jan; 245(1):16-23. PubMed ID: 17470365
[TBL] [Abstract][Full Text] [Related]
30. Cyclin D2 compensates for the loss of cyclin D1 in estrogen-induced mouse uterine epithelial cell proliferation.
Chen B; Pollard JW
Mol Endocrinol; 2003 Jul; 17(7):1368-81. PubMed ID: 12649329
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous downregulation of CDK inhibitors p18(Ink4c) and p27(Kip1) is required for MEN2A-RET-mediated mitogenesis.
Joshi PP; Kulkarni MV; Yu BK; Smith KR; Norton DL; van Veelen W; Höppener JW; Franklin DS
Oncogene; 2007 Jan; 26(4):554-70. PubMed ID: 16953232
[TBL] [Abstract][Full Text] [Related]
32. Preclinical activity of P276-00, a novel small-molecule cyclin-dependent kinase inhibitor in the therapy of multiple myeloma.
Raje N; Hideshima T; Mukherjee S; Raab M; Vallet S; Chhetri S; Cirstea D; Pozzi S; Mitsiades C; Rooney M; Kiziltepe T; Podar K; Okawa Y; Ikeda H; Carrasco R; Richardson PG; Chauhan D; Munshi NC; Sharma S; Parikh H; Chabner B; Scadden D; Anderson KC
Leukemia; 2009 May; 23(5):961-70. PubMed ID: 19151776
[TBL] [Abstract][Full Text] [Related]
33. A novel therapeutic combination using PD 0332991 and bortezomib: study in the 5T33MM myeloma model.
Menu E; Garcia J; Huang X; Di Liberto M; Toogood PL; Chen I; Vanderkerken K; Chen-Kiang S
Cancer Res; 2008 Jul; 68(14):5519-23. PubMed ID: 18632601
[TBL] [Abstract][Full Text] [Related]
34. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy.
Bartkova J; Rajpert-de Meyts E; Skakkebaek NE; Bartek J
J Pathol; 1999 Apr; 187(5):573-81. PubMed ID: 10398124
[TBL] [Abstract][Full Text] [Related]
35. Deregulation of the cyclin D1/Cdk4 retinoblastoma pathway in rat mammary gland carcinomas induced by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.
Qiu C; Shan L; Yu M; Snyderwine EG
Cancer Res; 2003 Sep; 63(18):5674-8. PubMed ID: 14522882
[TBL] [Abstract][Full Text] [Related]
36. Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present.
Casimiro MC; Velasco-Velázquez M; Aguirre-Alvarado C; Pestell RG
Expert Opin Investig Drugs; 2014 Mar; 23(3):295-304. PubMed ID: 24387133
[TBL] [Abstract][Full Text] [Related]
37. Cyclin D1 regulates p27(Kip1) stability in B cells.
Bustany S; Tchakarska G; Sola B
Cell Signal; 2011 Jan; 23(1):171-9. PubMed ID: 20837141
[TBL] [Abstract][Full Text] [Related]
38. Cell cycle-independent induction of D1 and D2 cyclin expression, but not cyclin-Cdk complex formation or Rb phosphorylation, by IFNgamma in macrophages.
Dey A; Li W
Biochim Biophys Acta; 2000 Jun; 1497(1):135-47. PubMed ID: 10838167
[TBL] [Abstract][Full Text] [Related]
39. Functional analysis of cyclin D2 and p27(Kip1) in cyclin D2 transgenic mouse mammary gland during development.
Kong G; Chua SS; Yijun Y; Kittrell F; Moraes RC; Medina D; Said TK
Oncogene; 2002 Oct; 21(47):7214-25. PubMed ID: 12370811
[TBL] [Abstract][Full Text] [Related]
40. Lineage specific composition of cyclin D-CDK4/CDK6-p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin.
Bryja V; Pacherník J; Vondráček J; Souček K; Čajánek L; Horvath V; Holubcová Z; Dvořák P; Hampl A
Cell Prolif; 2008 Dec; 41(6):875-893. PubMed ID: 19040567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]